文献速递血液净化与透析急性肾损伤慢性肾脏病

接受机械循环支持患者的透析管理

Management of Dialysis for Patients Receiving Mechanical Circulatory Support.
PubMed 文献 · J Am Soc Nephrol · 2025-12-24

机械循环支持用于心源性休克和终末期心衰,支持时长从数小时到数年不等。心肾相互作用及心肾代谢疾病流行导致机械循环支持与透析常需同时使用,透析需求从心源性休克相关急性肾损伤的短期透析到左心室辅助装置(LVAD)终身治疗进展至慢性肾脏病(CKD)G5期的长期透析不等。本文讨论临时和持久机械循环支持中透析的特殊考虑,包括容量管理和并发症风险等挑战。

要点

  • 临时机械循环支持包括主动脉内球囊反搏、微轴流泵和静脉-动脉体外膜氧合,提供不同水平的循环支持。
  • LVAD多用于永久治疗,多数接受者生存超过5年,期间可能发生或进展肾功能不全。
  • LVAD患者 outpatient 透析可针对AKI或CKD G5期,采用中心间歇性血液透析、腹膜透析或家庭血液透析。

核心结论

  • 机械循环支持与透析同时使用面临容量管理和并发症风险等多方面临床挑战。
  • 应对挑战需要心脏科、肾内科等医疗专业人员、患者及照护者的密切合作与共同决策。

研究设计与样本

  • 综述类文章,讨论临时和持久机械循环支持患者透析管理的特殊考虑。

主要发现

  • 临时机械循环支持设备包括主动脉内球囊反搏、微轴流泵和静脉-动脉体外膜氧合,提供不同水平循环支持。
  • LVAD现主要用于永久治疗,多数接受者生存超过5年,期间肾功能可能发生或进展。
  • LVAD患者可进行中心间歇性血液透析、腹膜透析或家庭血液透析。

临床怎么用

  • 对临时机械循环支持患者,根据设备类型和临床情况考虑AKI或CKD G5期透析需求。
  • 对LVAD患者,可选用中心间歇性血液透析、腹膜透析或家庭血液透析进行门诊透析。
  • 管理需关注容量管理和并发症风险,并实施心脏科与肾内科等多学科协作和共同决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mechanical circulatory support is used to augment circulatory flow in cardiogenic shock and end-stage heart failure. Support can last from hours for temporary mechanical circulatory support to years for durable mechanical circulatory support. The physiologic relationship of heart and kidney function and the epidemic of cardio-kidney-metabolic disease lead to frequent use of simultaneous mechanical circulatory support and extracorporeal KRT (dialysis). The need for dialysis can range from short periods of AKI in cardiogenic shock to long-term dialysis for individuals who receive left ventricular assist devices (LVADs) for destination therapy in advanced heart failure and progress to CKD G5 with replacement therapy. Changes in technology, clinical evidence, and organ transplantation have led to major changes in mechanical circulatory support use. With temporary mechanical circulatory support, devices and clinical situations vary widely, with intra-aortic balloon pumps, microaxial flow pumps, and venoarterial extracorporeal membrane oxygenation providing different levels of circulatory support. Considerations for dialysis, whether for AKI or CKD G5, are discussed. In durable mechanical circulatory support, LVADs are now used primarily for permanent therapy, and most LVAD recipients survive for more than 5 years, time in which kidney dysfunction can develop or progress. Outpatient dialysis with LVADs is performed for both AKI and for CKD G5, with in-center intermittent hemodialysis, peritoneal dialysis, or home hemodialysis. This article discusses considerations specific to dialysis in temporary and durable circulatory support, including the challenging aspects of volume management and complication risks. Concurrent mechanical circulatory support and dialysis present diverse clinical challenges in patients with complex medical needs. Meeting this challenge requires close cooperation and shared decision making incorporating cardiologists, nephrologists, other medical professionals, patients, and their caregivers.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Walther CP, Nair AP. Management of Dialysis for Patients Receiving Mechanical Circulatory Support. J Am Soc Nephrol. 2025. PMID: 41563801. doi:10.1681/ASN.0000001013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。